This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Sleep Apnoea
and you are
between 18 and 64
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight [1]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance [2]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity [3]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.

Provided treatments

  • Other: Questionnaire
Tris trial is registered with FDA with number: NCT02403141. The sponsor of the trial is Imperial College London Diabetes Centre and it is looking for 1400 volunteers for the current phase.
Official trial title:
Abu Dhabi Sleep Apnea (ADSA) Study